ARK Proposes Functional Cures ETF Targeting Genetic Medicines

ARK Investment Management has filed for the ARK Functional Cures ETF, an actively managed strategy targeting biotechnology companies developing potentially curative genetic medicines. The fund will focus on businesses advancing one-time treatments intended to address the underlying causes of diseases rather than relying on continuous symptom management. The strategy seeks to capture the transition from chronic therapies toward functional cures, emphasizing companies developing innovative genetic approaches to treatment. The proposed ETF expects to obtain most of its investment exposure through total return swaps, supplemented by direct equity investments and potentially private securities.